GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $209,000 | -99.1% | 5,121 | -99.0% | 0.00% | -100.0% |
| Q4 2020 | $22,724,000 | -25.0% | 524,675 | -4.5% | 0.04% | -36.5% |
| Q3 2020 | $30,301,000 | -11.4% | 549,528 | +1.4% | 0.06% | -21.2% |
| Q2 2020 | $34,197,000 | +34.7% | 541,686 | +9.0% | 0.08% | +2.6% |
| Q1 2020 | $25,383,000 | -34.9% | 496,837 | +1.4% | 0.08% | -21.2% |
| Q4 2019 | $38,965,000 | +76.3% | 490,192 | +7.6% | 0.10% | +59.7% |
| Q3 2019 | $22,105,000 | +6.0% | 455,582 | +14.9% | 0.06% | +3.3% |
| Q2 2019 | $20,863,000 | -0.2% | 396,629 | +0.4% | 0.06% | +1.7% |
| Q1 2019 | $20,906,000 | +54.9% | 394,985 | +20.2% | 0.06% | +31.1% |
| Q4 2018 | $13,493,000 | +89.2% | 328,740 | +75.2% | 0.04% | +125.0% |
| Q3 2018 | $7,133,000 | – | 187,664 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 595,473 | $25,790,000 | 4.19% |
| Grace Capital | 131,549 | $5,697,000 | 3.60% |
| Fernwood Investment Management, LLC | 201,657 | $8,734,000 | 3.44% |
| Fairmount Funds Management LLC | 215,000 | $9,312,000 | 3.33% |
| Arctis Global LLC | 293,700 | $12,720,000 | 2.74% |
| Perceptive Advisors | 5,674,711 | $245,771,000 | 2.64% |
| ArchPoint Investors | 217,510 | $9,420,000 | 2.61% |
| Alerce Investment Management, L.P. | 126,270 | $5,469,000 | 2.15% |
| Profit Investment Management, LLC | 42,196 | $1,826,000 | 1.17% |
| Affinity Asset Advisors, LLC | 50,000 | $2,166,000 | 1.15% |